{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:23:43Z","timestamp":1768739023473,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pathological corneal hem- and lymphangiogenesis are prime risk factors for corneal graft rejection. Fine needle-diathermy (FND) is an option to regress corneal blood vessels; however, whether this treatment besides clinically visible blood vessels also affects invisible lymphatic vessels is so far unknown. Here we test the hypothesis that FND destroys not only blood but also lymphatic vessels, thereby promotes corneal high-risk graft survival. The effect of FND was studied <jats:italic>in vivo<\/jats:italic> using BALB\/c mice and the model of suture-induced corneal neovascularization. Mice were divided into three groups: FND, ANTI (anti-inflammatory therapy) and NON (control). Five, 7, 10 and 20 days after cauterization, corneas were harvested and stained with LYVE-1, CD31 to quantify (lymph)angiogenesis. The long-term survival of allografts was compared between the three groups. FND caused significant regression of both blood and lymphatic vessels compared to the control group at all time points (p\u2009&lt;\u20090.05) with the most obvious effect at day 7 (p\u2009&lt;\u20090.01). Graft survival was significantly prolonged when transplants were placed into the FND pretreated group (p\u2009&lt;\u20090.0001). The effect of the anti-inflammatory therapy alone was less effective compared to FND (p\u2009&lt;\u20090.05). This novel lymphangioregressive effect of FND can be used clinically to precondition high-risk recipients to promote graft survival.<\/jats:p>","DOI":"10.1038\/s41598-018-24037-3","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T03:24:36Z","timestamp":1522812276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Fine Needle-Diathermy Regresses Pathological Corneal (Lymph)Angiogenesis and Promotes High-Risk Corneal Transplant Survival"],"prefix":"10.1038","volume":"8","author":[{"given":"Viet Nhat Hung","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Charlott","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"24037_CR1","doi-asserted-by":"publisher","first-page":"11405","DOI":"10.1073\/pnas.0506112103","volume":"103","author":"C Cursiefen","year":"2006","unstructured":"Cursiefen, C. et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc. Natl. Acad. Sci. USA 103, 11405\u201311410 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"24037_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.preteyeres.2013.01.001","volume":"34","author":"F Bock","year":"2013","unstructured":"Bock, F. et al. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Prog. Retin. Eye Res. 34, 89\u2013124 (2013).","journal-title":"Prog. Retin. Eye Res."},{"key":"24037_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee, P., Wang, C. C. & Adamis, A. P. Ocular neovascularization: An epidemiologic review. Surv. Ophthalmol. 43, 245\u2013269 (1998).","journal-title":"Surv. Ophthalmol."},{"key":"24037_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nri1224","volume":"3","author":"JW Streilein","year":"2003","unstructured":"Streilein, J. W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3, 879\u2013889 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"24037_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10792-007-9099-9","volume":"28","author":"EM Chong","year":"2008","unstructured":"Chong, E. M. & Dana, R. M. Graft failure IV. Immunologic mechanisms of corneal transplant rejection. Int. Ophthalmol. 28, 209\u2013222 (2008).","journal-title":"Int. Ophthalmol."},{"key":"24037_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4049\/jimmunol.0903180","volume":"184","author":"T Dietrich","year":"2010","unstructured":"Dietrich, T. et al. Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation. J Immunol 184, 535\u2013539 (2010).","journal-title":"J Immunol"},{"key":"24037_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/bjo.35.11.718","volume":"35","author":"N Ashton","year":"1951","unstructured":"Ashton, N., Cook, C. & Langham, M. Effect of cortisone on vascularization and opacification of the cornea induced by alloxan. Br. J. Ophthalmol. 35, 718\u2013724 (1951).","journal-title":"Br. J. Ophthalmol."},{"key":"24037_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1097\/ICO.0b013e31829ebb0d","volume":"32","author":"H Kim","year":"2013","unstructured":"Kim, H. et al. Presurgical corticosteroid treatment improves corneal transplant survival in mice. Cornea 32, 1591\u20131598 (2013).","journal-title":"Cornea"},{"key":"24037_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.exer.2014.06.006","volume":"125","author":"P Mirabelli","year":"2014","unstructured":"Mirabelli, P., Peebo, B. B., Xeroudaki, M., Koulikovska, M. & Lagali, N. Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model. Exp. Eye Res. 125, 118\u2013127 (2014).","journal-title":"Exp. Eye Res."},{"issue":"Suppl","key":"24037_CR10","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1097\/ICO.0b013e3182a2c937","volume":"32","author":"M Shimmura-Tomita","year":"2013","unstructured":"Shimmura-Tomita, M. et al. Keratoplasty postoperative treatment update. Cornea 32(Suppl), S60\u2013S64 (2013).","journal-title":"Cornea"},{"key":"24037_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archophthalmol.2011.42","volume":"129","author":"D Hos","year":"2011","unstructured":"Hos, D. et al. Suppression of Inflammatory Corneal Lymphangiogenesis by Application of Topical Corticosteroids. Arch Ophthalmol 129, 445\u2013452 (2011).","journal-title":"Arch Ophthalmol"},{"key":"24037_CR12","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","volume":"116","author":"C Cursiefen","year":"2009","unstructured":"Cursiefen, C. et al. GS-101 Antisense Oligonucleotide Eye Drops Inhibit Corneal Neovascularization. Interim Results of a Randomized Phase II Trial. Ophthalmology 116, 1630\u20131637 (2009).","journal-title":"Ophthalmology"},{"key":"24037_CR13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.ophtha.2014.03.038","volume":"121","author":"C Cursiefen","year":"2014","unstructured":"Cursiefen, C. et al. Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: The I-CAN study. Ophthalmology 121, 1683\u20131692 (2014).","journal-title":"Ophthalmology"},{"key":"24037_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0161-6420(92)31996-7","volume":"99","author":"JC Baer","year":"1992","unstructured":"Baer, J. C. & Foster, C. S. Corneal Laser Photocoagulation for Treatment of Neovascularization: Efficacy of 577 nm Yellow Dye Laser. Ophthalmology 99, 173\u2013179 (1992).","journal-title":"Ophthalmology"},{"key":"24037_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang, J. H., Gabison, E. E., Kato, T. & Azar, D. T. Corneal neovascularization. Curr. Opin. Ophthalmol. 12, 242\u2013249 (2001).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"24037_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bjo.60.6.464","volume":"60","author":"PMH Cherry","year":"1976","unstructured":"Cherry, P. M. H. & Garner, A. Corneal neovascularization treated with argon laser. Brit. J. Ophthal 60, 464\u2013473 (1976).","journal-title":"Brit. J. Ophthal"},{"key":"24037_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/bjo.66.2.127","volume":"66","author":"RJ Marsh","year":"1982","unstructured":"Marsh, R. J. & Marshall, J. Treatment of lipid keratopathy with the argon laser. Br. J. Ophthalmol. 66, 127\u2013135 (1982).","journal-title":"Br. J. Ophthalmol."},{"key":"24037_CR18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00003226-199109000-00012","volume":"10","author":"R Epstein","year":"1991","unstructured":"Epstein, R., Hendricks, R. & Harris, D. Photodynamic therapy for corneal neovascularisation. Cornea 10, 424\u2013432 (1991).","journal-title":"Cornea"},{"key":"24037_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0161-6420(88)33211-2","volume":"95","author":"AJW Huang","year":"1988","unstructured":"Huang, A. J. W., Watson, B. D., Hernandez, E. & Tseng, S. C. G. Induction of Conjunctival Transdifferentiation on Vascularized Corneas by Photothrombotic Occlusion of Corneal Neovascularization. Ophthalmology 95, 228\u2013235 (1988).","journal-title":"Ophthalmology"},{"key":"24037_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","volume":"57","author":"JH Chang","year":"2012","unstructured":"Chang, J. H. et al. Corneal Neovascularization: An Anti-VEGF Therapy Review. Surv. Ophthalmol. 57, 415\u2013429 (2012).","journal-title":"Surv. Ophthalmol."},{"key":"24037_CR21","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","volume":"247","author":"Y Koenig","year":"2009","unstructured":"Koenig, Y. et al. Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin\u00ae) eye drops against corneal neovascularization. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 247, 1375\u20131382 (2009).","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"24037_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/bjo.87.1.101","volume":"87","author":"C Cursiefen","year":"2003","unstructured":"Cursiefen, C., Hofmann-Rummelt, C., K\u00fcchle, M. & Schl\u00f6tzer-Schrehardt, U. Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation. Br J Ophthalmol 87, 101\u2013106 (2003).","journal-title":"Br J Ophthalmol"},{"key":"24037_CR23","first-page":"2148","volume":"41","author":"CT Pillai","year":"2000","unstructured":"Pillai, C. T., Dua, H. S. & Hossain, P. Fine needle diathermy occlusion of corneal vessels. Investig. Ophthalmol. Vis. Sci. 41, 2148\u20132153 (2000).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"24037_CR24","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/bjophthalmol-2014-304891","volume":"98","author":"L Faraj","year":"2014","unstructured":"Faraj, L., Elalfy, M., Said, D. & Dua, H. S. Fine needle diathermy occlusion of corneal vessels. Br J Ophthalmol 98, 1287\u20131290 (2014).","journal-title":"Br J Ophthalmol"},{"key":"24037_CR25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3126\/nepjoph.v3i1.4274","volume":"3","author":"S Thatte","year":"2011","unstructured":"Thatte, S. Fine needle diathermy \u2013 A choice for managing corneal vascularization. Nepal J Ophthalmol 3, 23\u201326 (2011).","journal-title":"Nepal J Ophthalmol"},{"key":"24037_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/bjophthalmol-2013-303729","volume":"98","author":"S Trikha","year":"2014","unstructured":"Trikha, S., Parikh, S., Osmond, C., Anderson, D. F. & Hossain, P. N. Long-term outcomes of Fine Needle Diathermy for established corneal neovascularisation. Br J Ophthalmol 98, 454\u2013458 (2014).","journal-title":"Br J Ophthalmol"},{"key":"24037_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","volume":"31","author":"Y Koenig","year":"2012","unstructured":"Koenig, Y., Bock, F., Kruse, F. E., Stock, K. & Cursiefen, C. Angioregressive Pretreatment of Mature Corneal Blood Vessels Before Keratoplasty: Fine-Needle Vessel Coagulation Combined With Anti-VEGFs. Cornea 31, 887\u2013892 (2012).","journal-title":"Cornea"},{"key":"24037_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/ICO.0000000000000419","volume":"34","author":"U Elbaz","year":"2015","unstructured":"Elbaz, U., Mireskandari, K., Shen, C. & Ali, A. Corneal Fine Needle Diathermy With Adjuvant Bevacizumab to Treat Corneal Neovascularization in Children. Cornea 34, 773\u2013777 (2015).","journal-title":"Cornea"},{"key":"24037_CR29","first-page":"1","volume":"18","author":"R Hussain","year":"2016","unstructured":"Hussain, R. & Savant, V. Fine-Needle Diathermy with Simultaneous Subconjunctival Bevacizumab. Semin. Ophthalmol. 18, 1\u20133 (2016).","journal-title":"Semin. Ophthalmol."},{"key":"24037_CR30","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","volume":"117","author":"B Bachmann","year":"2010","unstructured":"Bachmann, B., Taylor, R. S. & Cursiefen, C. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: An evidence-based meta-analysis. Ophthalmology 117, 1300\u20131305 (2010).","journal-title":"Ophthalmology"},{"key":"24037_CR31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/ICO.0000000000001444","volume":"37","author":"VNH Le","year":"2018","unstructured":"Le, V. N. H., Hou, Y., Horstmann, J., Bock, F. & Cursiefen, C. Novel Method to Detect Corneal Lymphatic Vessels In Vivo by Intrastromal Injection of Fluorescein. Cornea 37, 267\u2013271 (2018).","journal-title":"Cornea"},{"key":"24037_CR32","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.1167\/iovs.17-22286","volume":"58","author":"J Horstmann","year":"2017","unstructured":"Horstmann, J. et al. Label-free in vivo Imaging of Corneal Lymphatic Vessels using Microscopic Optical Coherence Tomography. Invest. Ophthalmol. Vis. Sci. 58, 5880\u201386 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"24037_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ophtha.2015.02.012","volume":"122","author":"N Spiteri","year":"2015","unstructured":"Spiteri, N. et al. Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization. Ophthalmology 122, 1079\u20131084 (2015).","journal-title":"Ophthalmology"},{"key":"24037_CR34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00417-002-0496-5","volume":"240","author":"M K\u00fcchle","year":"2002","unstructured":"K\u00fcchle, M. et al. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 240, 580\u2013584 (2002).","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"24037_CR35","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S0041-1345(99)00010-X","volume":"31","author":"JW Streilein","year":"1999","unstructured":"Streilein, J. W., Yamada, J., Dana, M. R. & Ksander, B. R. Anterior Chamber-Associated Immune Deviation, Ocular Immune Privilege, and Orthotopic Corneal Allografts. Transplant. Proc. 31, 1472\u20131475 (1999).","journal-title":"Transplant. Proc."},{"key":"24037_CR36","first-page":"413","volume":"37","author":"JW Streilein","year":"1996","unstructured":"Streilein, J. W., Bradley, D., Sano, Y. & Sonoda, Y. Immunosuppressive Properties of Tissues Obtained From Eyes With Experimentally Manipulated Corneas. Investig. Ophthalmol. Vis. Sci. 37, 413\u2013424 (1996).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"24037_CR37","first-page":"2176","volume":"36","author":"Y Sano","year":"1995","unstructured":"Sano, Y., Ksander, B. R. & Streilein, W. Fate of Orthotopic Corneal Allografts in Eyes That Cannot Support Anterior Chamber-Associated Immune Deviation Induction. Investig. Ophthalmol. Vis. Sci. 36, 2176\u20132185 (1995).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"24037_CR38","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen, C. et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113, 1040\u20131050 (2004).","journal-title":"J. Clin. Invest."},{"key":"24037_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.exer.2008.08.007","volume":"87","author":"F Bock","year":"2008","unstructured":"Bock, F. et al. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp. Eye Res. 87, 462\u2013470 (2008).","journal-title":"Exp. Eye Res."},{"key":"24037_CR40","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/00007890-199210000-00026","volume":"54","author":"Y Sonoda","year":"1992","unstructured":"Sonoda, Y. & Streilein, J. W. Orthotopic corenal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply. Transplantation 54, 694\u2013704 (1992).","journal-title":"Transplantation"},{"key":"24037_CR41","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen, C. et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Investig. Ophthalmol. Vis. Sci. 45, 2666\u20132673 (2004).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"24037_CR42","first-page":"2127","volume":"43","author":"C Cursiefen","year":"2002","unstructured":"Cursiefen, C. et al. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Investig. Ophthalmol. Vis. Sci. 43, 2127\u20132135 (2002).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"24037_CR43","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1167\/iovs.06-0570","volume":"48","author":"F Bock","year":"2007","unstructured":"Bock, F. et al. Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis. Investig. Ophthalmol. Vis. Sci. 48, 2545\u20132552 (2007).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"24037_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ajpath.2015.09.012","volume":"186","author":"D Hos","year":"2016","unstructured":"Hos, D. et al. IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages. Am. J. Pathol. 186, 159\u2013171 (2016).","journal-title":"Am. J. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24037-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:08:43Z","timestamp":1671595723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24037-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24037"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24037-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"assertion":[{"value":"4 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5707"}}